Salvador-Carulla L, Bertelli M, Martinez-Leal R. The road to 11th edition of the International classification of diseases: trajectories of scientific consensus and contested science in the classification of intellectual disability/intellectual developmental disorders. Curr Opin Psychiatry. 2018;31(2):79–87.

Article  PubMed  Google Scholar 

Arora P, Polson DW. Diagnosis and management of premature ovarian failure. Obstetrician Gynaecologist. 2011;13(2):67–72.

Article  Google Scholar 

Tucker EJ, Grover SR, Bachelot A, Touraine P, Sinclair AH. Premature ovarian insufficiency: New perspectives on Genetic cause and phenotypic spectrum. Endocr Rev. 2016;37(6):609–35.

Article  PubMed  Google Scholar 

Pal L, Torrealday S, Kodaman P. Premature ovarian insufficiency - an update on recent advances in understanding and management. F1000Research. 2017;6:2069.

Rudnicka E, Kruszewska J, Klicka K, Kowalczyk J, Grymowicz M, Skórska J, et al. Premature ovarian insufficiency - aetiopathology, epidemiology, and diagnostic evaluation. Przeglad Menopauzalny. 2018;17(3):105–8.

PubMed  PubMed Central  Google Scholar 

Murabito JM, Yang Q, Fox C, Wilson PWF, Cupples LA. Heritability of age at natural menopause in the framingham heart study. J Clin Endocrinol Metab. 2005;90(6):3427–30.

Article  CAS  PubMed  Google Scholar 

Weinberg-Shukron A, Rachmiel M, Renbaum P, Gulsuner S, Walsh T, Lobel O, et al. Essential role of BRCA2 in ovarian development and function. N Engl J Med. 2018;379(11):1042–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Persani L, Rossetti R, Cacciatore C, Fabre S. Genetic defects of ovarian TGF-β-like factors and premature ovarian failure. J Endocrinol Investig. 2011;34(3):244–51.

Article  CAS  Google Scholar 

Moriwaki M, Moore B, Mosbruger T, Neklason DW, Yandell M, Jorde LB, et al. POLR2C mutations are associated with primary ovarian insufficiency in women. J Endocr Soc. 2017;1(3):162–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA - J Am Med Association. 2014;312(18):1870–9.

Article  CAS  Google Scholar 

Henarejos-Castillo I, Aleman A, Martinez-Montoro B, Gracia-Aznárez FJ, Sebastian-Leon P, Romeu M, et al. Machine learning-based approach highlights the use of a genomic variant profile for precision medicine in ovarian failure. J Personalized Med. 2021;11(7):609.

Article  Google Scholar 

Morris AP, Zeggini E. An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol. 2010;34(2):188–93.

Article  PubMed  Google Scholar 

Povysil G, Petrovski S, Hostyk J, Aggarwal V, Allen AS, Goldstein DB. Rare-variant collapsing analyses for complex traits: guidelines and applications. Nat Rev Genet. 2019;20(12):747–59.

Article  CAS  PubMed  Google Scholar 

Asimit JL, Day-Williams AG, Morris AP, Zeggini E. ARIEL and AMELIA: testing for an accumulation of rare variants using next-generation sequencing data. Human Hered. 2012;73(2):84–94.

Article  CAS  Google Scholar 

Lee S, Abecasis GR, Boehnke M, Lin X. Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet. 2014;95(1):5–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gumpinger AC, Lage K, Horn H, Borgwardt K. Prediction of cancer driver genes through network-based moment propagation of mutation scores. Bioinformatics. 2020;36(Suppl1):I508–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scelsi MA, Napolioni V, Greicius MD, Altmann A. Network propagation of rare variants in Alzheimer’s disease reveals tissue-specific hub genes and communities. PLoS Comput Biol. 2021;17(1):e1008517.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56–68.

Article  PubMed  PubMed Central  Google Scholar 

Sebastian-Leon P, Vidal E, Minguez P, Conesa A, Tarazona S, Amadoz A, et al. Understanding disease mechanisms with models of signaling pathway activities. BMC Syst Biol. 2014;8(1):121.

Article  PubMed  PubMed Central  Google Scholar 

Cheng F, Zhao J, Wang Y, Lu W, Liu Z, Zhou Y, et al. Comprehensive characterization of protein–protein interactions perturbed by disease mutations. Nat Genet. 2021;53(3):342–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bestetti I, Barbieri C, Sironi A, Specchia V, Yatsenko SA, de Donno MD, et al. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency. Hum Reprod. 2021;36(11):2975–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K, et al. Mutant cohesin in premature ovarian failure. N Engl J Med. 2014;370(10):943–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grive KJ, Gustafson EA, Seymour KA, Baddoo M, Schorl C, Golnoski K et al. TAF4b regulates oocyte-specific genes essential for meiosis. Barsh GS, editor. PLoS Genetics. 2016;12(6):e1006128.

Huhtaniemi I, Hovatta O, La Marca A, Livera G, Monniaux D, Persani L, et al. Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency. Trends Endocrinol Metabolism. 2018;29(6):400–19.

Article  CAS  Google Scholar 

França MM, Mendonca BB. Genetics of primary ovarian insufficiency in the next-generation sequencing era. J Endocr Soc. 2020;4(2):1–16.

Article  Google Scholar 

Lobell AS, Kaspari RR, Serrano Negron YL, Harbison ST. The genetic architecture of ovariole number in Drosophila melanogaster: genes with major, quantitative, and pleiotropic effects. G3: Genes Genomes Genet. 2017;7(7):2391–403.

Lopez J, Coll J, Haimel M, Kandasamy S, Tarraga J, Furio-Tari P, et al. HGVA: the human genome variation archive. Nucleic Acids Res. 2017;45(W1):W189–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Byrska-Bishop M, Evani US, Zhao X, et al. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell. 2022;185(18):3426–3440.e19.

Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886–94.

Article  CAS  PubMed  Google Scholar 

Tian Y, Pesaran T, Chamberlin A, Fenwick RB, Li S, Gau CL, et al. REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification. Sci Rep. 2019;9(1):1–6.

Article  Google Scholar 

Hopkins JJ, Wakeling MN, Johnson MB, Flanagan SE, Laver TW. REVEL is better at Predicting pathogenicity of loss-of-function than gain-of-function variants. Hum Mutat. 2023;2023(1):8857940.

Google Scholar 

Niroula A, Vihinen M. How good are pathogenicity predictors in detecting benign variants? PLoS Comput Biol. 2019;15(2):e1006481.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhan X, Hu Y, Li B, Abecasis GR, Liu DJ. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics. 2016;32(9):1423–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morales J, Pujar S, Loveland JE, Astashyn A, Bennett R, Berry A, et al. A joint NCBI and EMBL-EBI transcript set for clinical genomics and research. Nature. 2022;604(7905):310–5.

Article  CAS  PubMed  PubMed Central